OngoingEUCTR 2007-007538-21
A Multi-center, Inpatient and ambulatory, Proof of Concept Study of CYR-101 in people with DSM-IV Schizophrenia
This study is ongoing in France. It is testing CYR-101 for schizophrenia.
In FranceSchizophreniaOther
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedEUCTR 2017-001447-12
A Placebo- and Active controlled study Efficacy of Brexpiprazole Monotherapy for the Treatment in Adolescents (13-17 years old) With Schizophr...
This study is completed in France, in Hungary, in Spain, .... It focuses on Schizophrenia.
In FranceSchizophreniaOther
CompletedEUCTR 2019-001989-15
Fremanezumab for Depression
This study is completed in France, in Germany, in Czech Republic, .... It is testing fremanezumab for Depression.
In FranceDepressionOther
Active Not RecruitingNCT06809595
Study of MM120 for Generalized Anxiety Disorder (Panorama)
This study is active but not recruiting in the United States, in France, in the United Kingdom, .... It focuses on anxiety.
In FranceAnxietyOtherFrom 18 Years to 74 Years
OngoingEUCTR 2022-001515-10
Safety and Efficacy of KarXT for Schizophrenia
This study is ongoing in France, in Spain, in Slovakia, .... It is testing Safety and Efficacy of KarXT for Schizophrenia.
In FranceSchizophreniaOther
CompletedNCT04359875
A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment
This study is completed. It focuses on mental health and currently lists study information in France.
Remote / onlineMental healthBehavioralFrom 18 Years to 110 Years
CompletedNCT05841030
A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
This study is completed in the United States, in France, in Canada, .... It focuses on depression.
In FranceDepressionOtherFrom 18 Years to 74 Years
CompletedNCT00261443
Aripiprazole (Abilify) in people with Bipolar Mania
This study is completed in the United States, in France, in Brazil, .... It is testing aripiprazole (Abilify) for manic episodes in bipolarity.
In FranceBipolarityDrugA study involving a medication or substance.Over 18 Years
CompletedNCT05550532
Aticaprant 10 Milligrams (mg) for Depression
This study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.
In FranceDepressionDrugFrom 18 Years to 74 Years
TerminatedNCT05518149
Aticaprant in Adult and Elderly people with Major Depressive Disorder (MDD)
This study has public registry information in the United States, in Australia, in France, .... It is testing aticaprant for depression.
In FranceDepressionDrugFrom 18 Years to 74 Years
TerminatedNCT06635135
Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression
This study has public registry information in the United States, in France, in Belgium, .... It is testing aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression.
In FranceDepressionDrugFrom 18 Years to 64 Years
CompletedNCT03345342
Paliperidone Palmitate 6-Month Formulation
This study is completed in the United States, in Australia, in France, .... It focuses on Schizophrenia.
In FranceSchizophreniaDrugFrom 18 Years to 70 Years